Within Drug Delivery Systems
GENINVO Launches Its Latest Offering – Datalution
GenInvo, a leading provider of life science product and business solutions announced the launch of its new, on-demand service: Datalution. GenInvo has recognized various challenges the pharmaceutical industry faces, especially in generating data for clinical trials. The need of clinical data to... - March 11, 2023 - GenInvo, Inc.
GENINVO Service Offering Custom Application Development
GENINVO is a leading provider of high-quality, innovative life science tools. GENINVO understand the business challenges of enterprises big and small. Whether you need short-term, focused design support or turnkey product development, GENINVO has the right tools to meet your needs with the help of... - September 07, 2022 - GenInvo, Inc.
Peptineo, LLC Selected by EPA to Provide EPA Nationwide Coverage for Point of Care (POC) COVID-19 Testing
The Environmental Protection Agency (EPA), Cincinnati Acquisition Division (CAD), has awarded Peptineo LLC, an emerging aerospace, health services, and defense solutions company, a three-year Blanket Purchase Agreement (BPA) to support a comprehensive COVID-19 testing program in support of the... - August 07, 2022 - Peptineo
Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results
Global Cancer Technology, a San Diego, CA biotechnology company, has successfully completed animal testing with GCT.GLIO.1, a PI3K selective inhibitor that can cross the blood brain barrier and modulate immune cell function. The company will advance the compound to Phase 1 clinical trials as a next step. - July 08, 2022 - Global Cancer Technology
GENINVO Launches Its Latest Offering - Innovation as a Service
GENINVO, a leading provider of life science product and business solutions announced the launch of its new, on-demand service: Innovation as a Service. GENINVO has recognized various challenges the pharmaceutical industry faces, especially in the wake of the pandemic. The need to expedite clinical... - June 12, 2022 - GenInvo, Inc.
Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology
Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. - May 21, 2022 - Global Cancer Technology
GENINVO Launches Centre of Excellence for Data Science and Analytics to Help Clients Unlock Insights Using Data Science
GENINVO, a leading provider of life sciences product and business solutions organization, announced the launch of a Centre of Excellence for Data Science and Analytics (DSA CoE). The DSA is a resolute team of experts comprising of life science and technology domains. Data Science and Analytics CoE... - November 18, 2021 - GenInvo, Inc.
Noble Paws CBD Joins Forces with Leading Pet Diabetes Brand
The pet CBD brand with an ethos, Noble Paws, donates a bottle of their healing CBD to a shelter every time one is purchased. Noble Paws has joined forces with rising star pet diabetes brand, PetTest, to reach as many pets as possible and “hemp” spread the word. - November 04, 2021 - Noble Paws
GENINVO Launches Updated New Website
After months of hard work and dedication, GENINVO is pleased to announce the new and updated website launch. The primary goal of the redesign process was to create a user-focused design, add improved functionality, and provide easy access to information about GENINVO’s products and services. - June 14, 2021 - GenInvo, Inc.
AltuCell Therapeutics Announces Proof-of-Concept in Lead Programs in Type 1 Diabetes in Human Subjects; Phase 1 Pilot in Humans Has IND Approval & Trial to Begin Shortly
AltuCell Therapeutics, Inc., AltuCell announced today the achievement of approval of IND in Italy after pre-clinical proof-of-concept based on data from its two lead programs for type 1 diabetes testing of cadaver stem cell-derived islets in both human and non-human subjects. Their capsules have been implanted in people with diabetes for 5 year, demonstrating long-term safety, with no toxicity or tissue necrosis, and no rejection in any of the patients treated. - January 15, 2021 - AltuCell Therapeutics
A Novel Treatment Modality for COVID-19: Global Cancer Technology is Developing a Nanoparticle Which May Selectively Target, Bind and Inactivate Coronavirus Virions
Global Cancer Technology, an emerging biopharmaceutical company, is developing a novel treatment modality to selectively kill the COVID-19 virus. - December 30, 2020 - Global Cancer Technology
3Sixty Pharma Solutions Announces Successful Approval of FDA Investigational New Drug Application
3Sixty Pharma Solutions LLC., www.3sixtypharma.com, has announced the successful submission to FDA, and approval of, an Investigational New Drug (IND) Application on behalf of one of its clinical-stage biotech clients. 3Sixty Pharma Solutions’ 360 Start-Up arm continues to be committed to... - October 15, 2020 - 3Sixty Pharma Solutions
Part B Access for Seniors and Physicians (ASP) Coalition Statement Regarding the Trump Administration’s Recently Announced Executive Order
The Part B Access for Seniors and Physicians (ASP) Coalition released the following statement regarding the Trump Administration’s recently announced Executive Order: “In a letter to lawmakers in 2018, the ASP Coalition warned about the International Pricing Index Model (IPI) and the... - July 24, 2020 - Part B Access for Seniors and Physicians Coalition
GENINVO Celebrates Its Anniversary
A year ago, GENINVO was carved out of a CRO to provide innovative technology solutions and services to the life sciences industry to enable them to deliver drugs faster with higher quality and cost-efficiency. Today GENINVO is partnering with all sizes of Biopharma companies around the world and we... - July 10, 2020 - GenInvo, Inc.
GENINVO CEO Shweta Shukla Announces Upcoming Launch of Shadow(TM) Version2
GENINVO would like to thank its teams for staying on track during these stressful times. While it is easy to lose focus of what is important during this unexpected COVID-19 time, the teams are working from home and have used this as an opportunity to bond with their teammates and collaborate with... - June 18, 2020 - GenInvo, Inc.
Experimentica Ltd. Announces the Successful Acquisition of the Ophthalmic Contract Research Division from Ophthy-DS, Inc.
Experimentica Ltd., a leader in preclinical ophthalmic drug discovery services, announces the successful acquisition of the contract research division from Ophthy-DS, Inc., a Michigan-based preclinical contract research organization (CRO) specializing in non-regulated drug discovery services and medical device testing for ophthalmic indications. - May 22, 2020 - Experimentica Ltd
GenInvo Supports Pharma Companies Working to Find a Cure for COVID-19 Virus, as Well as Supporting Their Employees as They Work from Home
GenInvo strives to support the drug development process to find treatments quickly and cost effectively. They are a dedicated part of the solution. Having their employees work from home, not only keeps the employees' and their family's healthy, it also keeps the company on track for developing life-saving solutions and innovative products to the Life Science/Pharma Industry faster. - April 01, 2020 - GenInvo, Inc.
3Sixty Pharma Solutions Partners with Westchester Biotech Project
Leveraging its “360Start-Up” Powerhouse to Grow a Dynamic Non-Profit for Scientists - January 11, 2020 - 3Sixty Pharma Solutions
GenInvo launches to provide innovative and transformative solutions to the pharma industry to help bring life-changing treatments to patients faster. - December 23, 2019 - GenInvo, Inc.
3Sixty Pharma Solutions Announces Successful Submission of Start-Up Biotech Investigational New Drug Application
3Sixty Pharma Solutions LLC, www.3sixtypharma.com, last week announced the successful submission to FDA of its first Investigational New Drug (IND) Application on behalf of one of its start-up biotech clients. This news comes on the heels of the formal organization in 2018 of 3Sixty Pharma... - December 16, 2019 - 3Sixty Pharma Solutions
RE Pharmacy Opens New Infusion Center in San Diego, CA
As RE Pharmacy progresses forward as a leader in the specialty pharmacy and infusion therapy industry, they have opened a new infusion center located inside the medical building at 7625 Mesa College Drive in San Diego. It shares the second floor with Neurologist Dr. Ian Purcell MD, PhD., boasts... - December 11, 2019 - River's Edge Pharmacy
RE Pharmacy Announces New Infusion Center in Phoenix, AZ
RE Pharmacy announces a new infusion center, in partnership with neurologist David Saperstein, MD and the the Center of Complex Neurology in Phoenix, AZ. - October 03, 2019 - River's Edge Pharmacy
New Xcenda White Paper Discusses Why the International Pricing Index Model is Not the Answer to Reforming Medicare Part B
White Paper Highlights Impact of IPI Model on Patients and Health Care Providers - May 09, 2019 - Part B Access for Seniors and Physicians Coalition
RE Pharmacy Announces New Headquarters to Accommodate Rapid Growth
After years of expansion, RE Pharmacy is pleased to announce the moving of their corporate headquarters. Located in Irvine, California, the two-story headquarters was chosen for its ample space and open floorplans. The layout of the building will allow for added employees and possible pharmacy... - April 19, 2019 - River's Edge Pharmacy
RE Pharmacy Announces New Website Launch
RE Pharmacy, a leader in specialty pharmacy and infusion services, announced today their newly designed corporate website, https://www.repharmacy.com. The overhauled website features streamlined and simplified mobile viewability, improved functionality, and enriched content. The purpose of the new... - April 17, 2019 - River's Edge Pharmacy
Are Antioxidants the Solution to Burning and Itchy Eyes?
A recently published study in The Ocular Surface journal authored by Experimentica Ltd. in collaboration with researchers from Loyola University Chicago and the University of Missouri – Kansas City suggests that a topical antioxidant formulation can improve the pathological signs associated with dry-eye disease. - March 26, 2019 - Experimentica Ltd
Patient & Provider Groups Oppose Legislation to Enable International Reference Pricing for Seniors’ Drugs
Coalition believes proposal by Sen. Sanders, Reps. Khanna and Cummings is likely to restrict access to lifesaving medicines and lead to adverse unintended consequences. - January 11, 2019 - Part B Access for Seniors and Physicians Coalition
339 Groups Urge Congress to Halt International Pricing Index Model
Part B Access for Seniors and Physicians Coalition-organized letter highlights model’s threats to patient choice and American healthcare innovation. - December 18, 2018 - Part B Access for Seniors and Physicians Coalition
New Report: ASP Rates Do Not Encourage Doctors to Prescribe High-Cost Drugs.
Coalition stresses findings of new report as policymakers consider potentially harmful changes to the Medicare Part B program - December 18, 2018 - Part B Access for Seniors and Physicians Coalition
Experimentica Ltd. Presents at the ISER in Belfast, Northern Ireland - XXIII Biennial Meeting of the International Society for Eye Research September 9-13, 2018 | Belfast
The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting COO of Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase mimetic and the dry-eye disease. Dr Simon Kaja – CSO of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection. - September 08, 2018 - Experimentica Ltd
Gensco Pharma’s Transdermal Colchicine, ColciGel®, for Treatment of Acute Gout Flares with Negligible Systemic Absorption Improving Tolerability with Less Side Effects
New transdermal therapy available for gout sufferers with negligible systemic absorption improving tolerability and minimizing side effects. ColciGel for Acute Gout Flares is now available at your participating local retail pharmacy. - June 26, 2018 - Gensco Pharma
LayerBio to Present Preclinical Results for Extended Release Glaucoma Formulation at ARVO
LayerBio will present preclinical study results at the Association for Research in Vision and Ophthalmology in Honolulu, Hawaii on Monday, April 30. These results demonstrate the therapeutic potential of its novel extended-release travoprost formulation using LayerBio's proprietary PolyNet™ delivery technology. - April 27, 2018 - LayerBio, Inc.
Value Drug Scores Big in Pharmaceutical Returns
PharmaLink is the New Partner in Drug Returns Processing Value Drug, a top-rated wholesaler to independent pharmacies, announced another industry leading initiative with PharmaLink. Together they will now provide to all of their members a full array of services in the take back and processing of... - March 14, 2018 - PharmaLink
Experimentica Ltd. Amongst the Most Promising Finnish Young Innovative Companies
Experimentica Ltd. has been selected for Phase 1 of the Young Innovative Company program by Business Finland (formerly known as TEKES, The Finnish Funding Agency for Technology and Innovation). The funding awarded for the first phase is a 250,000 € grant for a period of 12... - February 21, 2018 - Experimentica Ltd
Creative BioMart to Expand Its Protein Glycosylation Labeling Service Capacity to Meet Rising Demands
Creative BioMart, a global leader in the supply of high quality protein products and efficient protein manufacturing techniques, today announced a major expansion of its Protein Glycosylation Labeling Service capacities as a response to rising customer needs and market demands for characterizing... - November 26, 2017 - Creative Biomart
Tanner Pharma Group to Attend Upcoming CPHI Worldwide Conference
Top executives from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend the CPhI Worldwide event on October 24 – 26 in Messe Frankfurt, Germany. Tanner Pharma leverages more than 15 years of pharma services experience to... - October 21, 2017 - Tanner Pharma Group
Drugshoppe Selected as Finalist for 2017 Innovation Conference and Showcase
Drugshoppe was selected as a finalist in the first annual pitch competition at the Houston Technology Center Innovation Conference and Showcase. Drugshoppe was picked from among many companies that applied in the fields of life sciences, aerospace, energy, IT, and transportation. Drugshoppe will... - September 14, 2017 - Drugshoppe
Pharmaceutical Company CJSC "ARAY" Announces Construction of Pharmaceutical Plant with Two Hormonal Drugs Research, Development and Production in Bishkek, Kyrgyzstan
Pharmaceutical company CJSC ARAY announced today that it is in active research and development phase of a new Hormone Replacement Therapy (HRT) drug, called SUSTADREN (TM), housed in Bishkek, Kyrgyz Republic. - August 19, 2017 - CJSC ARAY
Responsive Health Selected to Attend New Jersey Founders & Funders Event
Leader in Digital Medicine Will Attend April 27 Event. - April 25, 2017 - Rx.Health
Responsive Health Announces Strategic Expansion Into New Jersey Healthcare Market
Pioneer in Digital Medicine Expands Northeast Presence - April 19, 2017 - Rx.Health
KeyCentrix™ Announces Integration with myDataMart
FDS & myDataMart offer professional, comprehensive and affordable business solutions that immediately impact pharmacy profitability by providing tools to manage patients, third party receivables, Star Ratings, immunization opportunities, MTM cases and much, much more. By providing a deeper look into each pharmacy's data, myDataMart can help better manage pharmacy operations and increase profits. - February 23, 2017 - KeyCentrix
Experimentica Ltd. Appoints New Director of In Vivo Pharmacology
Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Tamuna Bolkvadze, Ph.D. to Director In Vivo Pharmacology, effective immediately. Dr. Bolkvadze joined Experimentica Ltd. earlier in 2016 as Research Scientist and has been instrumental... - October 22, 2016 - Experimentica Ltd
Tabula Rasa HealthCare to Present Medication Therapy Management Innovations at MTM Summit September 15-16, 2016
Tabula Rasa HealthCare's (TRHC) Medication Risk Mitigation Matrix(R) brings to Enhanced Medication Therapy Management (EMTM) the ability to identify those Medicare beneficiaries at the highest risk of an adverse drug event and mitigates that risk through personalized interventions. - September 07, 2016 - Tabula Rasa HealthCare
Cannabis Manifesto Issues Urgent Wake-Up Call to Global Society
The Dà Má Collective has released "Dissolving The Stigma Against Nature’s Oldest & Safest Medicine: a manifesto," which aims to correct public opinion towards the healing herb known as cannabis. The 7-page illustrated manifesto makes the case, supported by 11,000+ years of hard evidence, that any stigma surrounding the use of cannabis (the notion that cannabis is somehow ‘naughty’) is unfounded and unsustainable. - September 06, 2016 - The Da Ma Collective
KinderPharm to Celebrate Grand Opening of New Exton Office
Pennsylvania Elected Officials to Participate in Ribbon-Cutting Ceremony and Grand Opening Event; KinderPharm is pleased to announce that it will hold a Grand Opening event and Ribbon-Cutting ceremony for its new office at 100 Arrandale Blvd., Exton, Pennsylvania on Friday, August 26th from 1 p.m. to 3 p.m. The event will feature a ribbon-cutting ceremony at 1 p.m., food and refreshments, and industry networking. - August 16, 2016 - KinderPharm LLC
TruInject Founder Gabrielle Rios Receives Nomination for Innovator of the Year from the Orange County Business Journal
TruInject Medical Corp™ is pleased to announce the nomination of Innovator of the Year by the Orange County Business Journal. - August 09, 2016 - Truinject Medical Corp.
Tabula Rasa HealthCare's Jack Russell Software Innovation Center Kick Off First JRS Coding School Boot Camp September 19
The Jack Russell Software Innovation Center (JRS IC) announced today its first Coding School Boot Camp will be held September 19, - December 6, 2016. Applications must be submitted between August 1 – September 1, 2016. The JRS IC was launched this year by TRHC to develop technology that will solve real health care problems while providing leading-edge value to software innovation. In celebration, a 50% discount off of the tuition is being offered to students. - August 05, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare Launches Jack Russell Software Innovation Center; Tom Wilson Named Executive VP/Chief Technology Innovation Officer
The new JRS IC will provide technology leadership, creativity and training to TRHC and its subsidiaries, as well as the healthcare community at large. Programs and events are designed to engage and collaborate with highly trained professionals in fields of software development, while creating a culture that continuously innovates and focuses on patient safety. - August 05, 2016 - Tabula Rasa HealthCare
Saffa Compounding Pharmacy/Sunshine Care Partners Tulsa. Saffa Pharmacy Announced as Sunshine Care Partners Territory License Owner for Tulsa County, OK.
Saffa Compounding Pharmacy is proud to announce its purchase of the Sunshine Care Partners, Tulsa County Territory, and welcomes territory owners Debra Wells DPh, and Karla Taylor, both residents of Tulsa County. Tulsa County physicians serving Chronic Care Patients can partner with Saffa/Sunshine who, after serving the community for over 42 years, is expanding their services to both physicians and patients. - July 07, 2016 - Saffa Compounding Pharmacy
Tabula Rasa HealthCare Subsidiary Medliance Promotes Rebstock to Executive Director
TRHC Chairman and CEO Calvin H. Knowlton named Candy Rebstock Executive Director of its wholly-owned subsidiary, Medliance, which is the leading pharmacy cost management solution for post-acute care. Clients rely on Medliance's adjudication and consulting services to create transparency and increase communication between client skilled nursing facilities and their pharmacy partners. - June 20, 2016 - Tabula Rasa HealthCare